Cases & Deals

Faron Pharmaceuticals completes placing of Ordinary Shares on AIM

Clients Faron Pharmaceuticals Oy

Jones Day represented Faron Pharmaceuticals Oy, a clinical stage biopharmaceutical company based in Turku, Finland, in connection with the placing of Ordinary Shares on the Alternative Investment Market (AIM). Cairn Financial Advisors acted as nominated advisor. Panmure Gordon acted as joint nominated broker and bookrunner. Whitman Howard acted as joint nominated broker.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.